News
This could be a pivotal year for Vodafone as the board seeks to reset the business and reverse a long-term share price ...
Glencore’s share price has fallen a lot this year, which may mean a major bargain to be had. I took a deep dive into the ...
After stepping down as Berkshire Hathaway CEO, Warren Buffett has passed the torch to Greg Abel. What does this mean for the ...
As Diploma’s latest results blow expectations out of the water, the share price is surging. But what should investors make of ...
Our writer investigates how some residential landlords may turn to the stock market as a better option to provide a second ...
Nvidia has been topping up its stake in new IPO firm CoreWeave (NASDAQ:CRWV). Should I buy this AI growth stock that's ...
Like-for-like sales growth is starting to recover at Greggs and the share price is climbing as a result. So is the worst now ...
At the start of 2025, this Fool picked three S&P 500 stocks to beat the market over the next five years. But has he already ...
This investor takes a look at the FTSE 250's best-performing stock over the past six weeks. Is it a buy for his Stocks and ...
Since its IPO in February 2021, our writer’s been following this FTSE 250 legend with interest. But lately, he notices ...
Looking for passive income investments? Our writer highlights three dividend stocks to consider from the banking, media, and ...
Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results